Photoacoustic imaging (PAI) provides information on haemoglobin levels and blood oxygenation (sO 2 ). To facilitate assessment of the variability in sO 2 and haemoglobin in tumours, for example in response to therapies, the baseline variability of these parameters was evaluated in subcutaneous head and neck tumours in mice, using a PAI system (MSOT-inVision-256TF). Tumours of anaesthetized animals (midazolam-fentanyl-medetomidine)
Introduction
The immature, tortuous and hyper-permeable vascular network often found in tumours may not provide sufficient nutrients and oxygen for rapid and uncontrolled cell proliferation, which can result in regions of tumour cell hypoxia, i.e. low oxygen concentration in the vicinity of tumour cells [1] . Temporal fluctuations in the hypoxic state also occur [2] , on a time-scale of minutes or hours when they result from an efflux of red blood cells, or days when they are due to vascular network remodelling and angiogenesis [3] .
Hypoxia is associated with increased resistance to chemo-and radio-therapy (as extensively reviewed by Rockwell et al. [4] ), two commonly used clinical cancer treatments. Assessing the spatial and temporal variation in hypoxia levels could be predictive of a cancer therapy response and may therefore play a critical role in treatment planning and adaptation [5, 6] .
Conventionally, oxygen needle electrodes have been used to assess hypoxia in patients, by directly measuring tissue partial oxygen pressure (pO 2 ) [7] . However, needle electrodes are invasive and provide only a local value, which is not representative of the whole tumour.
Techniques which use conventional non-invasive imaging have been developed to attempt to infer, not only the oxygenation levels, but also the spatial distribution of hypoxia. Several Positron Emission Tomography (PET) radiotracers are available [8] [9] [10] which are molecules that are reduced in the absence of oxygen and covalently bind to intracellular molecules, providing a non-invasive alternative, albeit with a relatively poor spatial resolution and high cost. Unfortunately, the use of radioactive isotopes is also ill-suited to longitudinal studies due to radiation dose accumulation. Blood oxygenation level dependent (BOLD) magnetic resonance imaging (MRI) [11] enables the measurement of relative blood oxygen saturation (sO 2 ) increase during carbogen challenge compared to air-breathing, within tumours. It has been shown that these measurements are in good spatial agreement with tissue pO 2 measurements [12] [13] [14] and histological markers of hypoxia [15, 16] . BOLD-MRI, however, has poor specificity for hypoxia, and does not provide absolute sO 2 .
Recently, the use of combined ultrasound (US) and optical imaging techniques, such as photoacoustic imaging (PAI), also known as optoacoustic imaging, has been proposed as a method of non-invasively mapping blood oxygen saturation [17, 18] . PAI combines the merits of optical and ultrasound imaging, displaying optical absorption contrast with sub-millimetre spatial resolution at depths of several centimetres in tissue. Light is absorbed differentially depending on the relative concentrations of light-absorbing molecules present [19] . As a result, PAI can identify the unique spectral signatures of deoxy-(Hb) and oxy-haemoglobin (HbO 2 ) [17] . The quantification of the local levels of each chromophore further allows mapping of blood sO 2 distribution in the tissue, defined as the ratio of oxygenated haemoglobin (HbO 2 ) to the total amount of haemoglobin (HbT, the sum of HbO 2 and deoxyhaemoglobin, Hb) [19, 20] . Low sO 2 regions tend to be hypoxic [21] . PAI has been used for hypoxia mapping pre-clinically, in subcutaneous [15, 18, 20, [22] [23] [24] [25] and brain tumours [26] , showing good agreement with pimonidazole staining [18, 22] , an exogenous hypoxia marker [15] , and imaging modalities, such as bioluminescence [20] , high resolution and dynamic contrast enhanced ultrasound [20, 23] and BOLD-MRI [24, 25] .
This paper aims to characterise the variability of photoacoustic imaging measurements of Hb, HbO 2 , HbT and sO 2 in subcutaneous head and neck tumours, commonly hypoxic, using a commercial tomographic photoacoustic system. The long term application for this study would be to use the baseline measurements obtained here, in tumour-bearing control animals, in future longitudinal imaging studies where two cancer therapies will be used, radiotherapy and high intensity focused ultrasound (HIFU). This baseline information is valuable to assess the significance of any difference in pre-treatment blood sO 2 or haemoglobin levels from the mean across the tumours and any effect of the treatments on these parameters, as it has been reported in the literature that both these therapies can alter the vasculature and/or the oxygenation status of tumours after being delivered [27] [28] [29] .
Therefore, this study aims to obtain baseline measurements of the variation in the photoacoustic imaging measurements over the short term (<75 minutes), to investigate the potential effects of both anaesthetic duration and altering the position of the animal, as well as over the longer term (6 days), to evaluate the variations in growing tumours. The human head and neck squamous cell tumour model, CAL R , used for this study is a noncommercially available cancer cell line developed at the Institute of Cancer Research [30] .
Methods

Animal experiments
Half a million cells were injected subcutaneously into the right flank of 6 week old female FOXnu n1 mice (~25 g). Animals were monitored for the development of a mass. Once palpable, tumour dimensions were measured every 2 or 3 days, in 3 orthogonal directions (length (l), width (w) and height (h)), using Vernier calipers. Tumour volume (V) was calculated assuming an ellipsoidal shape, commonly used for subcutaneous tumours, according to Eq. 1.
The volume error (V error ), for each individual tumour, was estimated from the derivative of an ellipsoidal volume, assuming a measurement error (E m ) of 0.5 mm in each direction, using Eq. 2.
Eq. 2
Tumour dimensions are therefore presented as mean volume plus standard deviation of the estimate based only on the accuracy of the three orthogonal dimension measurements, ignoring any deviation in shape from an ellipsoid.
Tumour growth rates
Tumour growth curves were fitted to the Exponential-Linear Model to calculate tumours' growth rates [31] . The model assumes that cells initially proliferate with constant cell cycle duration, T c , resulting in exponential growth, followed by a linear growth phase, when there is a decrease in actively proliferating cells and these are constrained to the margins of the tumour [32] . The model is described as follows:
where V is tumour volume (mm 3 ), t is time (days),  0 is the growth rate during the exponential phase, i.e. the fraction of proliferating cells at time ln2/T c ,  1 is the growth rate in the linear phase and  represents the time point at which the growth changes from the exponential to the linear phase. Assuming the solution is continuously differentiable then:
where V 0 is the initial volume, in this case 0.1 mm 3 , chosen as an arbitrary small initial volume of tumour cells.
The tumour growth fitting was carried out in MATLAB (2013a, 8.1.0.604), using a nonlinear least squared fit to obtain the α 0 and α 1 parameters. Fits were performed on volume data weighted using the measurement uncertainties of each data point, which corresponded to the V error calculated from Eq. 2, within 95% confidence interval bounds.
Photoacoustic imaging data acquisition and reconstruction
Mice were imaged using a commercially available, real time, multispectral optoacoustic tomographic (MSOT) device, inVision 256-TF small animal scanner (iThera Medical GmbH, Munich, Germany) [33] . The system has a tunable optical parametric oscillator pumped by a Q-switched Nd:YAG near-infrared laser. A 256 element, toroidally focused, ultrasound imaging transducer (4 cm radius) with a centre frequency of 5 MHz (60% bandwidth) was used to acquire the acoustic signal, resulting from the optical tissue excitation. These elements cover an angle of 270 degrees around the tumour to create a cross-sectional image.
Tumours were first imaged (defined as Day1) when they reached a volume of approximately 200 mm 3 . Anaesthesia was induced using an intraperitoneal injection of midazolam:fentanyl:medetomidine (5.0:0.05:0.5 mg.Kg -1 ). Mice were placed horizontally in a holder encased in a thin (17 m) polyvinyl chloride (PVC) film ( Fig.1) , with their tumour facing vertically downwards, i.e. directly in the direction of the laser beam, and acoustically coupled to the membrane using ultrasound imaging gel. In order to provide acoustic coupling to the MSOT, the animal holder was completely submerged in a tank filled with 34 o C distilled water. Medical air (21% oxygen) and/or 100%-oxygen were supplied continuously to the mouse via tubing during immersion in order to avoid asphyxiation. Imaging started approximately 5 minutes after placing the holder in the water tank, in order to allow the animal's body temperature to equilibrate with the water's temperature.
For acquiring the photoacoustic data, a volume of interest (VOI), containing the whole tumour was selected to avoid a large dataset. Transverse (medial-lateral direction) imaging slices were acquired at 1 mm intervals in the cranial-caudal direction. The optical imaging wavelengths used were: 700, 715, 730, 750, 760, 800, 850, and 900 nm. This wavelength range maximises the differences in Hb and HbO 2 signals. Ten signal averages per wavelength were obtained for each imaging slice.
Photoacoustic images were reconstructed using a model-based inversion algorithm [34] which was implemented in the viewMSOT software (v3.8) provided by iThera Medical.
Spectral unmixing was used to calculate the contribution of each chromophore, oxy-and deoxy-haemoglobin, in blood, in order to calculate the oxygen saturation. This is done on a pixel-by-pixel basis, through a linear regression algorithm [35] . The software subsequently allows calculation of the mean oxy-(HbO 2 ) and deoxy-haemoglobin (Hb) signals in a user defined region of interest (ROI) which could be drawn onto the greyscale anatomical image ( Fig. 2A ). These mean Hb and HbO 2 values are added together to calculate the mean total haemoglobin per ROI. For any ROI the mean oxygen saturation was calculated using Eq. 5.
Eq. 5
All the parameters are unitless quantities, described in arbitrary units (A.U.), because the software does not take use light fluence and the system response in calculations, which would be necessary to quantify the concentration (in mmol/L or mg/L) of each chromophore.
For each 3D imaging scan, 3 slices were always chosen for the analysis of Hb, HbO 2 , HbT and sO 2 .
The viewMSOT software also allows mapping of the spatial distribution of sO 2 calculated on a pixel-by-pixel basis, an 'oxymap' (Fig. 2B ). Black pixels in such images indicate where the total amount of haemoglobin is so low, or sources of noise so high, that adequate confidence in spectral recognition cannot be achieved, or because the reconstruction method produces pixels with negative values. The intensity of such pixels is set to zero. The software automatically provides the percentage of black pixels per ROI.
Imaging studies
Three separate imaging studies were performed.
The first was a short term MSOT study designed to investigate any potential effects of anaesthesia on total haemoglobin and blood sO 2. A 3D whole tumour dataset was acquired every 5 minutes for 75 minutes after allowing 5 minutes for the tumour to reach thermal equilibrium with the imaging system. Only air-breathing imaging was acquired, in order to maximise the rate (and number) of datasets that could be acquired. Measurements were acquired in 4 animals when their tumours reached a target volume of 200 mm 3 .
The PAI optical fluence is depth-dependent, hence the position of tissue of interest with respect to the imaging transducer can affect the PAI measurements, as this can alter the amount of near-infrared light attenuated by overlying tissue as well as the field intensity incident on that position. In order to study how re-positioning the animal affects measurements of blood haemoglobin and blood sO 2 , a second short term study was performed, 24 hours after the first study. The same 4 animals were anaesthetised once and imaged in three consecutive sessions after being dismounted from the imaging system between each session. In addition, the tumour was placed at a slightly different position relative to the transducer each time. Whole tumour 3D datasets were acquired first under air breathing conditions which took approximately 2 minutes, and then under 100% oxygen breathing, after allowing 2 minutes for the oxygen to reach the tumour, for the same VOI, under hyperoxic conditions [25] . Oxygen breathing can be used as a contrast agent for PAI, enhancing tumour and spatial differences when vascularity is imaged using sO 2 [36] .
Approximately 4 minutes were needed to remove the animal from the holder, reposition it and replace it (see Fig. 3 ).
For both short-term studies, a linear regression model was applied to calculate an estimate of the average change in signal over time, as well as the goodness of fit between the imaging data and the model. This was obtained using the curve fitting toolbox (version 3. The third, a long-term study, was designed to sequentially image tumours during a period of growth. When tumours (n=10) reached a volume of approximately 200 mm 3 , animals were imaged on 3 consecutive days ('Day 1, 2 or 3'). This volume was chosen as being suitable for future studies of cancer treatment e.g. using radiotherapy. Tumours were also imaged on day 6 in order to evaluate changes in haemoglobin and blood sO 2 during tumour growth. For this study, animals were imaged under air-and oxygen-breathing conditions.
For short-and long-term studies, three slices in each tumour, separated by 1 mm, were chosen for analysis, a central slice and the adjacent slice on either side. The mean haemoglobin and blood sO 2 values were obtained by averaging over the three whole-tumour ROIs to provide the tumour ROI-averaged Hb, HbO 2 , HbT and sO 2 . For each animal, the average percentage of black pixels in the three central tumour slices was also calculated in order to evaluate the signal lost in each ROI.
Immunohistochemistry
Five tumours were collected after imaging for immunohistochemistry, including pimonidazole staining that binds to hypoxic ducts, and H&E to analyse tissue structure. Pimonidazole was administered to the animal intraperitoneally (60 mg/kg) 45 minutes before sacrificing it.
Tumour samples were excised and immediately snap frozen on dry ice and stored at -80 o C until sectioning.
For H&E staining, frozen tumour sections (10 µm thick) were counterstained in 'Harris'
haematoxylin (dyes cellular nuclei) and eosin (dyes cytoplasm and organelles). Samples were then dehydrated with a sequence of ethanols and xylene, and mounted using DPX mounting medium (Sigma-Aldrich, Dorset, UK). Acetone-fixed cryosections (consecutive to the ones used for H&E) were used to visualize pimonidazole adduct formation with an anti- 
Statistical analysis
The slice-, intra-tumour and inter-tumour coefficients of variation (CoVs), i.e. the ratio of standard deviation to mean, were calculated for Hb, HbO 2 , HbT and sO 2 in all PAI studies.
The first indicates how much variation to expect between the 3 ROIs chosen for the analysis of the PAI parameters; the second the variation of the measurements for each animal and the third the variation between animals.
A paired student t-test was used to assess the level/degree of significance of differences in the mean Hb, HbO 2 , HbT and sO 2 of CAL R tumours during the long term variability studies, on imaging days 1, 2, 3 and 6, using R software.
Results
Comparison between photoacoustic imaging and immunohistochemistry
Pimonidazole staining indicates the presence of widespread perfusion-limited or diffusion- The different change rates are quantified in Table 1 . Table 1 Table 1 also shows the increase in blood sO 2 . Animals 1, 2 and 4, had similar increases in blood sO 2 (range: 0.0027-0.0031), but for animal 3, the blood sO 2 rate of change was negligible, 0.00025 (3.148e-05, 0.00047), with R 2 = 0.267. This is a consequence of a similar increase in Hb (0.0079 min -1 ) and HbO 2 (0.0071 min -1 ). 
Re-positioning study
The results for the study on the effect of repositioning 4 animals three times in the photoacoustic system are shown in Figs. 6 and 7 . The trends for air-and oxygen-breathing were similar, so the results for air-breathing are shown here and the results for oxygenbreathing are in the supplementary material section ( Fig. S1 and Tables S3-4 ).
The where a high percentage of black pixels was measured. ROI-averaged blood sO 2 tended to increase for animals 3 and 4 but remain more constant for animals 1 and 2.
The quantification of the changes in signal, both for the individual haemoglobin components, blood sO 2 and percentage of black pixels, is shown in Table 2 . As observed in the 75 minutes imaging study, a trend for an increase in Hb (>0.0034 min -1 ), HbO 2 (>0.0050 min -1 )
and HbT (>0.0084 min -1 ) was observed over time. Animals 1 and 2 also showed a decrease in %BP (-0.852 min -1 and -0.162 min -1 ). For animal 3, since the blood sO 2 remained constant, R 2 was low (0.189), although SSE was also very low (<0.001), showing a good linear fit. The R 2 for the linear regression model applied in the re-positioning study for animal 4 was low for the blood sO 2 (0.153) and for individual haemoglobin components, <0.289. From Fig. 7 , it may be seen that, for this animal, position 2 had abnormally low haemoglobin and sO 2 values, which may explain the poor goodness of fit. The p-values in Table 2 show that the slopes, i.e. changes in signal over time, for Hb, HbO 2 , HbT and SO 2 , were not significantly different from zero. The slice-and intra-tumour CoVs for ROI-averaged Hb, HbO 2 , HbT and sO 2 , are summarised in Table S2 . The intra-tumour CoV measurement of animal four, excluding position 2, where 46% of signal was lost, is also shown. As was seen for the 75 minute study, the intra-tumour CoVs for measurements acquired after re-positioning the animals was higher for the haemoglobin components (Hb: 22.06.0%; HbO 2 : 40.011.0%; HbT:
28.15.1%) than for blood sO 2 Table S6 ).
The inter-and intra-tumour CoV for air-breathing photoacoustic imaging, for 4 imaging sessions acquired over 6 days, are summarised in Table S5 . As was found for the short term variability studies, the intra-and inter-tumour CoVs for the sO 2 parameter were lower (7.52.5% and 13.13.2%, respectively) than for the haemoglobin parameters (range 19.38.7% to 39.75.6%).
Tumour growth rate
Growth rates calculated for ten CAL R tumours used in the longitudinal study are shown in Table 3 . The individual fitted growth curves, as well as the exponential-linear model fitting, are shown in the supplementary material section (Fig. S6 ). The uncertainties (95% confidence intervals) are large and hence no statistically significant differences were found between individual tumour growth rates. The goodness of fit, R 2 , for the majority of the tumours (N=8) was ≥ 0.88, suggesting good agreement between the exponential-linear model and the data. Animals CAL R -1 and CAL R -8, had abnormally low fits to the model. CAL R -1 ulcerated, which can affect the tumour growth (see Fig. S6 ). Fig. S6 shows stagnated tumour growth (108±18 mm 3 to 123±20 mm 3 ) between days 12 to 20 after tumour implantation for CAL R -8. Table 6 shows that the time at which tumour growth changed from exponential to linear varied from 2 to 10 days after tumour implant. Based on these results and the growth curves shown in Fig. S6 , all photoacoustic imaging acquired for this study was performed during linear growth. In Fig. 8 , the change in blood sO 2 over the 6 days of imaging did not follow the same trend for all tumours, i.e. there was no statistically significant persistent increase or decrease in blood sO 2 between day 1 and day 6 of imaging. In order to investigate if these changes were related with change in volume over time (V), calculated using raw caliper volume measurements, or linear rate of tumour growth ( 1 ), estimated using the exponentiallinear model, the relationship between these parameters and the percentage difference in sO 2 between day 6 and day 1 was investigated and it is shown in Fig. 9 . It is possible to observe a good negative correlation between the percentage difference in sO 2 and both V and  1, but only during oxygen-breathing, i.e. the larger the change in sO 2 (oxygenbreathing), the faster the tumour was growing.
Discussion
The main objective of this paper was to explore the variation of the sO 2 , HbO 2 , Hb and HbT parameters in untreated subcutaneous head and neck tumours measured with a tomographic photoacoustic system, with time over short (minutes-hours) and long periods (several days), and with position of the animals in the imaging cradle. From these studies, it was possible to quantitatively investigate the variability due to anaesthesia, tumour growth and re-positioning. This baseline information will be required for assessing the significance of any changes in these characteristics that may be related to response to treatment, in future studies of the effects of radiotherapy and/or HIFU.
Initially, the spatial correspondence between photoacoustic images and histology staining for hypoxia was investigated ( Fig. 4 ). For this study, pimonidazole, a well-established exogenous marker of hypoxia, was used [37, 38] . Gerling et al. [18] had showed good agreement (R 2 = 0.915, p-value = 0.0028) between an increased intensity in pimonidazole and low sO 2 measured using photoacoustic imaging, although with a different tomographic PAI system to that used in this study. In 2016, Tzoumas et al. [39] , using the MSOT (iThera) system, also showed good congruence between pimonidazole staining distribution and low blood sO 2 measurements. The pimonidazole staining from our study, Fig. 4 , showed the presence of extensive tumour hypoxia, as has been observed previously using histology and BOLD-MRI with the same tumour model [40] . The pimonidazole distribution was generally in good spatial agreement with blue regions (Fig. 4) , i.e., low sO 2 , in the PAI 'oxymaps'. Fig. 4 also showed that black pixels in the PAI, where the level of haemoglobin falls below the noise threshold of the MSOT, or very dark blue regions (sO 2~0 ) probably correspond with necrotic regions, as seen in H&E images (A&D). This was expected since regions of depleted of vasculature rapidly become necrotic and acellular. Nevertheless, due to the different slice thicknesses of the techniques (10 m for histology and 900 m for PAI), it is not possible to perfectly co-register the two types of images and this may lead to discrepancies. This direct comparison between histology and PAI is also not possible because both modalities are used at different time points. PAI is done in vivo, while histology processing is done ex vivo and the samples are excised and frozen 45 minutes after imaging, which can contribute to differences between modalities, since hypoxia is variant in time. Despite of the challenges to achieve exact co-registration between histology and MSOT images, the pimonidazole stained tumour sections clearly demonstrated the potential of PAI to infer the spatial heterogeneity in hypoxia in tumours.
The photoacoustic signal variability over 75 minutes was measured to investigate whether the injectable anaesthesia could affect haemoglobin and blood sO 2 measured in tumours. Fig. 5 shows a decreasing trend of the black pixels, regions where HbT is too low to be measured, after the first 10 minutes of imaging. Shah et al. [23] showed, by co-registration of PAI (using this system) and microbubble contrast-enhanced ultrasound images, that the black regions in tumours (in mice) did not lack perfusion, although typically exhibited lower levels of perfusion and later microbubble arrival than other regions within the tumour. The MSOT and the software available at the moment are still 1 st generation and efforts are being made to improve the detection of HbT in order to eliminate the occurrence of black pixels.
During the 75 minutes in which in the percentage of black pixels tended to decrease, an increase in Hb, HbO 2 and HbT ( Fig. 5 and Table 1 ) was measured, resulting in increased blood sO 2 for 3 out of 4 animals. These results suggest peripheral vasodilation. The combination of medetomidine, fentanyl and midazolam used for this study has been shown to cause a significant increase in blood pressure in rabbits and rats, which could arise from an increase in vascular resistance or peripheral vasoconstriction, [41, 42] . However, it is well-known that the cardiovascular effects of the combination of these anaesthetic agents vary in different species [43] and to the authors' knowledge, there have been no reports on its effect in female FOXnu n1 mice. The increase in HbT and sO 2 in our study can be due to a cardiovascular effect of the anaesthetic agent combination; due to an influence of the hydrodynamic pressure, when the animal is enveloped in a plastic film and submerged inside the water tank; or due to an influence of the compression of the tumour due to the animal's body weight, which possibly stops blood outflow from the tumour. All these factors could have contributed to the trend that was observed and further work is necessary to understand its source.
The trend for an increase in haemoglobin was observed during the whole duration of imaging session, so the signal does not stabilise during an acceptable period of anaesthesia for a small animal. Therefore, this baseline change in signal needs to be considered in future studies, as it is not possible to wait for long enough for a stable signal before starting imaging the animal.
The inter-and intra-tumour CoVs (as shown in Table S1 ) were similar in this study, >16.0±8.4% and >20.9±3.1%, respectively, regarding the parameters analysed: Hb, HbO 2 ,
HbT and sO 2 . This reflects a high variation in the measured signal of each animal, expected due to the increasing trend in haemoglobin and blood sO 2 over time. Joseph et al. (2017) [44] studied the repeatability and reproducibility of PAI with the same system as that used here in the left kidney and spleen of 8-12 week old mice (n=7), acquiring images over a period of 90 minutes, under isoflurane anaesthesia. The authors found a steady increasing trend in HbT and blood sO 2 over the 90 minute imaging acquisition. The group reported that the intra-organ CoVs for haemoglobin (Hb, HbO 2 and HbT, measurements averaged over a single ROI) for spleen was below 16.4 and for kidney below 18.5, while for sO 2 these values dropped to 3.9 and 3.4, respectively. The CoVs measured in this paper during 75 minutes of imaging in subcutaneous tumours were higher than those measured in spleen and kidney, although it is not possible to compare the uncertainties in the measurements. In the experiment conducted by Joseph et al., the organs (spleen and left kidney) were located deep within the animal's body, so there is probably minimal compression of their blood supply due to mounting in the system, unlike the situation for subcutaneous tumour, located superficially. This is in addition to the deficient vascular supply that renders tumours prone to 'cyclic' hypoxia [2] , which can affect the measurements of haemoglobin and oxygen saturation.
In the second study, the effects of re-positioning the animal three times during one imaging session were analysed. Fig. 6 shows that the shape of the tumour may vary considerably during repositioning of the animal, changing the size of the tumour-ROI used for analysis.
Subcutaneous tumours, besides being subject to compression due to the animal's body weight acting against buoyancy, as well as due to hydrostatic pressure, can move relative to underlying anatomy as the skin can be highly mobile. Therefore, during longitudinal studies it would be important for the user to place the animal and tumour in the same position relative to the MSOT mouse holder. From Fig.6 , it is possible to observe differences in the 'oxymaps'
depending on the position of the animal, which can result in differences in the distribution and intensity of blue/red pixels. In mouse 4, position 2 resulted in an atypical high number of black pixels (46%), with corresponding uncharacteristically low levels of Hb, HbT and sO 2 .
However, this was observed in only one imaging scan, for one animal out of twelve, so the likelihood of this type of artefact is very low.
In order to investigate if the differences in 'oxymaps' during the re-positioning study also resulted in significant differences in ROI-averaged photoacoustic imaging measurements (Hb, HbO 2 , HbT and sO 2 ) over time, the temporal changes in these measurements were calculated. Fig.7 and Table 2 show a trend for an increase in Hb, HbO 2 , HbT and sO 2 over time, during the re-positioning study. The signal change reported in Table 2 shows a similar change for animals 1 to 3 for the haemoglobin components (range of 0.0094 to 0.019 for haemoglobin components and of 0.00041 to 0.0051 for sO 2 ) compared to that calculated for the 75 minute study (range of 0.0071 to 0.030 for haemoglobin components and of 0.00025 to 0.0031 for sO 2 ). A trend for a decrease or constant percentage of black pixels over time, in each position, was also observed for animals 1 and 2, as observed in the 75 minute imaging study. Animal 3 exhibited no trend in levels of sO 2 compared to the other two animals, consistent with the observations of the sequential imaging for a period of 75 minutes. Table 4 shows that for this study, the p-values were >0.05 so the slopes (change in signal) were not significantly different from zero. This is likely due to the scarce (n=3 positions) number of points, per animal.
From Figs. S2-S5, it is also possible to observe there were no significant differences between the various positions, for the slopes representing the variation over the 75 minutes of the imaging study. The imaging for animal 4, in position 2 that resulted in a large amount of black pixels, increased the inter-and intra-tumour CoV for the re-positioning study.
However, the majority of the signal in this imaging scan was lost, so it is not possible to know if this decrease is a result of changes in the tumour or simply an artefact due to the signal loss.
The inter-and intra-tumour CoV for the CAL R tumours due the re-positioning of the animal (Table S2 ) were >22.0±21.2% and >26.5±8.3%, respectively, for all the parameters (Hb, HbO 2 , HbT and sO 2 ), hence similar to those obtained for the study without re-positioning the animal (see Table S1 ), over a 75 minute period, apart from animal 4. This also suggests that anaesthesia is the main experimental factor that contributes for the temporal variability of the signal, as found by Joseph et al. [44] .
The 6 day longitudinal study of CAL R tumours showed no temporal trend in sO 2 or haemoglobin (Hb, HbO 2 and HbT) ( Fig. 8 In order to assess whether there was any dependence of tumour blood sO 2 on tumour growth, the growth rates of the 10 CAL R tumours during two different growth stages, were calculated using the exponential-linear model. The goodness of fit showed a good correlation (R 2 >0.8) between the model and 8 datasets. Of the two animals omitted from analysis, one of the tumours became ulcerated, which is known to introduce an error in tumour measurement [46] and the other animal showed an unexpected delay in tumour growth. Fig.   9 shows a good linear relationship between the linear growth rate and the variation in sO 2 (R 2 = 0.72, n=8), during oxygen-breathing. A good linear relationship was also found between the rate of change in volume calculated just for the 6 days of imaging and percentage change in sO 2 (R 2 = 0.67). Tumours that grew faster (n=5) during the linear phase (1> 20 mm.day -1 ) had a decrease in sO 2 [range of -10% to -56%] between days 1 and 6 of imaging, probably because they outgrew their blood supply before new vasculature could be formed. Slower growing tumours (n=3) exhibited an increase or no change in sO 2 [+12% and -1%], possibly because angiogenesis was occurring at a rate similar to the tumour growth rate. In this study, oxygen proved to be a good contrast agent to show the differences between tumours.
A limitation of this study is that it evaluated the baseline variations in the photoacoustic signal for only one tumour type, a subcutaneous head and neck tumour model. Other tumour types might show different variation. For example, Tomaszewski et al. [36] showed that two prostate tumour models, PC3 and LNCaP, exhibited different haemodynamic behaviour, as assessed by PAI.
Conclusions
This paper documents the variation in haemoglobin (Hb, HbO 2 and HbT) and oxygen saturation over short (up to 75 minutes) and long (6 days . Correlation between rate of change in volume between day 1 and 6 of imaging, V, or linear growth rate, 1, and the percentage difference in sO 2 between days 1 and 6 of imaging for 8 CAL R tumours, for air-and oxygen-breathing measurements.
